Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Top Scientist Goodman Prioritizes "Strengthening Our Scientific Approach"

This article was originally published in The Tan Sheet

Executive Summary

As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original focus: improving the agency's scientific capacity and integrity.
Advertisement

Related Content

FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
FDA Reorganization Elevates Scientific And Food Safety Priorities
FDA Pursues Consumer Products With Questionable Flu Treatment Claims
FDA Pursues Consumer Products With Questionable Flu Treatment Claims
Advisors Say FDA Funding Fails Science, Senators Pan Food Safety Plan

Topics

Advertisement
UsernamePublicRestriction

Register

PS103659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel